Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "stroke volume"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Estimates Of Central Hemodynamics Using Gas Exchange In Patients With Cystic Fibrosis
    (2016-07) Kasak, Alexander
    Pulmonary artery capacitance (PVCAP) is the ability of the pulmonary artery to accept a volume of blood at a given pressure. Traditionally measured invasively with heart catheterization; PaCAP may be estimated non-invasively through the measurement of end-tidal CO2 (PETCO2) and stroke volume (SV), known as gas-exchange capacitance (GXCAP) where a higher capacitance means improved pulmonary vasodilation. The degree of pulmonary vascular dysfunction at rest and during exercise remains unclear in patients with cystic fibrosis (CF). PURPOSE: To determine the effects of exercise on GXCAP in patients with CF, when compared to healthy subjects. METHODS: 19 patients with CF (age=22±2yrs, BMI=23±1kg/m2, VO2=56±6%pred., FVC=83±5%pred., FEV1=72±6%pred., FEV1/FVC=0.72±0.02) and 17 healthy subjects (age=22±1yrs, BMI=23±1kg/m2, VO2=81±5%pred., FVC=93±3%pred., FEV1=89±2%pred., FEV1/FVC=0.81±0.02) were recruited for this study. Exercise testing was performed on a cycle ergometer. PETCO2 was assessed using a metabolic cart, SV was assessed using the acetylene rebreathe technique and GXCAP was calculated from the product of PETCO2 and SV. RESULTS: At rest, SV and GXCAP were higher in healthy subjects when compared to CF (SV=72±6 vs. 54±5ml, GXCAP=22±2 vs. 17±2, for healthy and CF, respectively. PETCO2 remained unchanged between healthy and CF subjects (PETCO2 30±1 and 30±1 respectively). Healthy subjects exercised at a higher absolute intensity, but intensity expressed as a percentage of max was similar between healthy and CF (watts=159±10 vs. 102±8, watts/max watts=96±3 vs. 95±5% for healthy and CF, respectively). At peak exercise, SV and GXCAP increased in both healthy and CF but remained higher in healthy subjects when compared to CF (SV=108±5 vs. 84±6ml, GXCAP=40±3 vs. 29±2, for healthy and CF, respectively, p<0.05). When matched for a workload designed to match for SV, there was no difference in percent of max watts (%MaxW=63±4 vs. 66±5W), Q (11±1 vs. 13±1L/min), or SV (89±4 vs. 90±4ml/beat). When matched, the previous difference in GXCAP in healthy and CF was abolished (GXCAP=32±2 vs. 32±2mL/BEAT ∙ min). CONCLUSION: Gas exchange capacitance is lower in patients with CF at rest and through peak exercise. However, when matched for SV and workload, GXCAP was statistically similar between healthy and CF. This lower GXCAP is likely due to lower SV at rest and with peak exercise in CF patients, when compared to healthy subjects. Therefore, these findings suggest that there is no evidence of pulmonary vasculature dysfunction in these CF patients. Future, more invasive studies are warranted to confirm the lack of difference in pulmonary vascular function in patients with CF.